Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model.
- Published In:
- Acta biochimica et biophysica Sinica, 51(4), 411-421 (2019)
- Authors:
- Wu, Xiaoqiong, Pang, Yu, Zhang, Zhilin, Li, Xiabin, Wang, Chao, Lei, Yingqing, Li, Ailing, Yu, Ling, Ye, Jian
- Database ID:
- RPEP-04560
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04560APA
Wu, Xiaoqiong; Pang, Yu; Zhang, Zhilin; Li, Xiabin; Wang, Chao; Lei, Yingqing; Li, Ailing; Yu, Ling; Ye, Jian. (2019). Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model.. Acta biochimica et biophysica Sinica, 51(4), 411-421. https://doi.org/10.1093/abbs/gmz020
MLA
Wu, Xiaoqiong, et al. "Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model.." Acta biochimica et biophysica Sinica, 2019. https://doi.org/10.1093/abbs/gmz020
RethinkPeptides
RethinkPeptides Research Database. "Mitochondria-targeted antioxidant peptide SS-31 mediates neu..." RPEP-04560. Retrieved from https://rethinkpeptides.com/research/wu-2019-mitochondriatargeted-antioxidant-peptide-ss31
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.